知镜 Cognispect · 医学文献与研究工作台

Anti-SRP and anti-HMGCR co-positivity in immune-mediated necrotizing myopathy with interstitial lung disease: A rare case report.

Imran M, Javaid MH, Fareh Z, Wazir MA, Kamil KA.
Medicine · 2026-10-01 · PMID 43012761

文献摘要

Rationale Immune-mediated necrotizing myopathy (IMNM) is a rare inflammatory myopathy. Coexisting anti-signal recognition particle (anti-SRP) and anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibodies in statin-naïve patients with interstitial lung disease are exceptionally uncommon. Patient concerns A 55-year-old statin-naïve man presented with progressive proximal muscle weakness, dysphagia, myalgia, significant weight loss, and exertional dyspnea. Diagnoses Serum creatine kinase was 8000 U/L. Anti-SRP, anti-HMGCR, and anti-Ro52 antibodies were positive. Chest computed tomography showed bilateral consolidations and ground-glass opacities suggestive of organizing pneumonia. Pulmonary function tests revealed reduced forced vital capacity (52%) and diffusing capacity for carbon monoxide (48%). Electromyography and muscle biopsy findings supported IMNM. Interventions Treatment included high-dose corticosteroids, mycophenolate mofetil, nutritional support, and rehabilitation. Outcomes After 3 months, muscle strength improved from 3/5 to 4+/5, dysphagia resolved, and weight increased by 5 kg. Creatine kinase decreased to 350 U/L, forced vital capacity improved to 74%, and diffusing capacity for carbon monoxide to 65%. Follow-up high-resolution computed tomography showed pulmonary improvement without fibrosis. Lessons This case highlights the rare coexistence of anti-SRP and anti-HMGCR antibodies in statin-naïve IMNM with interstitial lung disease. Early immunosuppression, nutritional support, and rehabilitation may improve muscular and pulmonary outcomes. Comprehensive respiratory assessment and longitudinal monitoring are essential.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。